Skip to main content

Together we are beating cancer

Donate now

Cancer type

Showing 12 out of 2914 results
Cancer Research UK logo

Thousands more people would take part in bowel cancer screening if the kit included extras, such as gloves and “poo catchers”. Thousands more people would take part in bowel cancer screening if the kit included extras, such as gloves and “poo catchers”.

by Cancer Research UK | News | 7 October 2015

7 October 2015

A linear accelerator (via Wikimedia Commons)

Giving fewer but higher doses of radiotherapy, is as effective at treating prostate cancer as giving lower doses for a longer period, according to new research Giving fewer but higher doses of radiotherapy, is as effective at treating prostate cancer as giving lower doses for a longer period, according to new research

by Cancer Research UK | News | 28 September 2015

28 September 2015

Our scientists have discovered that similar to a rugby maul, cancer cells can ward off tumour-killing immune cells through an important cellular signal. Our scientists have discovered that similar to a rugby maul, cancer cells can ward off tumour-killing immune cells through an important cellular signal.

by Alan Worsley | Analysis | 25 September 2015

25 September 2015

Scientists have shown that a class of experimental drug treatments already in clinical trials could also help the body’s immune system to fight cancer. Scientists have shown that a class of experimental drug treatments already in clinical trials could also help the body’s immune system to fight cancer.

by Cancer Research UK | News | 24 September 2015

24 September 2015

Alan
  • Science & Technology
  • Health & Medicine

Our milestones: the birth of abiraterone for prostate cancer

We look back to the 1990s, and to our 'first-in-man' trial of prostate cancer drug abiraterone - a vital step in the drug's development We look back to the 1990s, and to our 'first-in-man' trial of prostate cancer drug abiraterone - a vital step in the drug's development

by Henry Scowcroft | Analysis | 21 September 2015

21 September 2015

This entry is part 24 of 30 in the series Our milestones
%postcontent%

More than half of people invited to take a new bowel cancer screening test didn’t take up the opportunity even though it could prevent the disease & save lives. More than half of people invited to take a new bowel cancer screening test didn’t take up the opportunity even though it could prevent the disease & save lives.

by Cancer Research UK | News | 21 September 2015

21 September 2015

We quiz our chief clinician, Professor Peter Johnson, to get his take on the history of cancer immunotherapy and where the field is heading. We quiz our chief clinician, Professor Peter Johnson, to get his take on the history of cancer immunotherapy and where the field is heading.

by Henry Scowcroft | Analysis | 17 September 2015

17 September 2015